It had all the elements of high stakes drama. An aggressive, deadly
disease was rapidly spreading around the globe. Quarantines were
going up. And health officials were scrambling to shut down the
new virus known as SARS.
"I was wondering what we could do," says Marco Marra,
a UBC associate professor and director of Canada's Michael Smith
Genome Sciences Centre (GSC) at the BC Cancer Agency. "And
I approached my colleagues with the idea to sequence the SARS virus."
That was on March 27.
By April 5, Marra's research team had obtained an RNA sample from
the National Microbiology Laboratory in Winnipeg and the B.C. Centre
for Disease Control. After working around the clock they announced
on April 11 that they had completed a draft DNA sequence of the
virus -- the first in the world.
"This was a significant step," explains Marra. "Scientists
now had the genetic information to develop tests for the presence
of the virus, and work on a vaccine."
Marra credits achievements like this to the vision of the late
Michael Smith, Nobel Laureate, UBC professor and founding director
of the GSC. He also credits Victor Ling, vice president of research
at the BC Cancer Agency, and vital funding from the B.C. Cancer
Foundation, which made the vision for the GSC a reality.
"Michael was instrumental in bringing me back to Canada,"
says Marra. "I couldn't pass up the opportunity to be mentored
by one of the world's leading thinkers." Marra himself mentors
UBC graduate students at the BC Cancer Agency, ensuring the legacy
of Michael Smith will live on in the quest for a cancer cure. |